Eurofins-Cerep SA (ALECR) - Total Liabilities
Based on the latest financial reports, Eurofins-Cerep SA (ALECR) has total liabilities worth €12.54 Million EUR (≈ $14.66 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Eurofins-Cerep SA - Total Liabilities Trend (2000–2025)
This chart illustrates how Eurofins-Cerep SA's total liabilities have evolved over time, based on quarterly financial data. See ALECR net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Eurofins-Cerep SA Competitors by Total Liabilities
The table below lists competitors of Eurofins-Cerep SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jinro Distillers Co. Ltd
KQ:018120
|
Korea | ₩14.06 Billion |
|
Elevate Uranium Ltd
AU:EL8
|
Australia | AU$1.52 Million |
|
Apetit Oyj
HE:APETIT
|
Finland | €37.60 Million |
|
Arla Plast AB
ST:ARPL
|
Sweden | Skr310.20 Million |
|
Matrimony.Com Limited
NSE:MATRIMONY
|
India | Rs2.20 Billion |
|
Ybox Real Estate Ltd
TA:YBOX
|
Israel | ILA999.76 Million |
|
Hasen-Immobilien AG
STU:ABHA
|
Germany | €83.22 Million |
|
Banco Santander Río S.A
BA:BRIO
|
Argentina | AR$19.89 Trillion |
Liability Composition Analysis (2000–2025)
This chart breaks down Eurofins-Cerep SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Eurofins-Cerep SA (ALECR) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eurofins-Cerep SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eurofins-Cerep SA (2000–2025)
The table below shows the annual total liabilities of Eurofins-Cerep SA from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €12.54 Million ≈ $14.66 Million |
+1.73% |
| 2024-12-31 | €12.32 Million ≈ $14.41 Million |
-15.79% |
| 2023-12-31 | €14.63 Million ≈ $17.11 Million |
+3.65% |
| 2022-12-31 | €14.12 Million ≈ $16.51 Million |
-1.63% |
| 2021-12-31 | €14.35 Million ≈ $16.78 Million |
+31.08% |
| 2020-12-31 | €10.95 Million ≈ $12.80 Million |
+5.12% |
| 2019-12-31 | €10.42 Million ≈ $12.18 Million |
+3.20% |
| 2018-12-31 | €10.09 Million ≈ $11.80 Million |
+13.76% |
| 2017-12-31 | €8.87 Million ≈ $10.37 Million |
+4.56% |
| 2016-12-31 | €8.49 Million ≈ $9.92 Million |
-16.91% |
| 2015-12-31 | €10.21 Million ≈ $11.94 Million |
+4.88% |
| 2014-12-31 | €9.74 Million ≈ $11.38 Million |
-33.03% |
| 2013-12-31 | €14.54 Million ≈ $17.00 Million |
-11.07% |
| 2012-12-31 | €16.35 Million ≈ $19.11 Million |
-14.65% |
| 2011-12-31 | €19.16 Million ≈ $22.39 Million |
-13.96% |
| 2010-12-31 | €22.26 Million ≈ $26.03 Million |
-12.37% |
| 2009-12-31 | €25.41 Million ≈ $29.70 Million |
-24.02% |
| 2008-12-31 | €33.44 Million ≈ $39.09 Million |
-13.86% |
| 2007-12-31 | €38.81 Million ≈ $45.38 Million |
-37.64% |
| 2006-12-31 | €62.25 Million ≈ $72.77 Million |
+18.53% |
| 2005-12-31 | €52.52 Million ≈ $61.40 Million |
+65.01% |
| 2004-12-31 | €31.83 Million ≈ $37.21 Million |
+47.48% |
| 2003-12-31 | €21.58 Million ≈ $25.23 Million |
+17.33% |
| 2002-12-31 | €18.39 Million ≈ $21.50 Million |
+24.89% |
| 2001-12-31 | €14.73 Million ≈ $17.22 Million |
+25.88% |
| 2000-12-31 | €11.70 Million ≈ $13.68 Million |
-- |
About Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and… Read more